|
Section 1 Epidemiology |
1. Prevalence of retinopathy Diabetic retinopathy is the commonest cause of blindness in the population of working age in developed nations and is of increasing importance in developing nations2,3. The prevalence of retinopathy varies with the age of onset of diabetes and the duration of the disease: in younger patients (below 30 years of age) the prevalence of retinopathy is minimal during the first 5 years but increases to greater than 95% after 15 years of diabetes4. in contrast, in patients whose onset of diabetes occurs after the age of 30, up to 20% may have signs of retinopathy on presentation with the prevalence in this group rising more slowly to approach 60% after 15 years of diabetes5. . In an insulin-treated subset of older-onset (>30 years) diabetic patients, 30% have signs of retinopathy at diagnosis, rising to over 80% after 25 years of diabetes. More recent data on patients with non-insulin dependent diabetes mellitus (NIDDM) as part of the UK Prospective Diabetes Survey (UKPDS) indicate that the prevalence of retinopathy at diagnosis is 38%, using a single microaneurysm as evidence of retinopathy6. . As a general statement, therefore, the prevalence of DR of any severity in the diabetic population as a whole is approximately 30%7. . 1.2 Prevalence of sight-threatening retinopathy Most cases of DR are non-sight threatening. However, the pre- valence of progressive retinopathy with risk of visual impairment is approximately 10%8. . Accurate figures for the prevalence of blindness (defined as VA <3/60 in the better eye) in the UK are not yet available. In the Wisconsin epidemiologic studies, the prevalence of proliferative retinopathy was 60% after 25 years of diabetes in younger diabetic patients, but in older diabetics it varied from 20 to 30% depending on whether they were insulin-treated or not. In contrast, diabetic macular oedema in 11% of younger diabetics and in 4% to 7% of older depending on their insulin requirement. Despite the lower overall rate of sight-threatening retinopathy in older patients, the prevalence of visual disability is greater in this group due to the much larger numbers of patients with NIDDM9. More recent data has shown that the incidence of macular oedema over a 10 year period was 20% in young diabetics, 25% in older age diabetics taking insulin and 14% in non-insulin-taking older diabetics. In addition, there appeared to be a correlation between incidence of macular oedema and poor diabetic control (see later)10. . The prevalence of blindness due to DR has thus been estimated to be approximately 5% (range 3-7%)11 and may be as high as 8%1. The annual incidence of new cases of sight-threatening retinopathy in the UK has been estimated to be approximately 1.2% of diabetics12. In order to eliminate this, screening programmes aimed a the diabetic population at risk of sight-threatening retinopathy, are presently being developed. Pilot studies indicate that 2.5-3% per annum of the screened population would require referral to an ophthalmologist. |
|
|
|